Patents Assigned to Genoscreen
  • Use of the ornithine transcarbamylase (), as a marker for diagnosing brain damages
    Patent number: 8114624
    Abstract: The present invention pertains to the domain of brain diseases, and provides novel markers and methods for diagnosing a brain alteration in an individual, especially in patients suffering from neurodegenerative diseases such as Alzheimer's disease. The present invention also provides tools for evaluating the probability, for an individual, of developing the disease, as well as a target for identifying new drugs for treating neurodegenerative diseases such as Alzheimer's disease. In particular, the invention provides a genetic marker based on combination of two single nucleotide polymorphism, at positions ?389 and ?241 of the ornithine transcarbamylase (OTC) gene.
    Type: Grant
    Filed: April 18, 2007
    Date of Patent: February 14, 2012
    Assignees: Genoscreen, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Philippe Amouyel, Jean-Charles Lambert, Stéphanie Ferreira
  • Use of the Ornithine Transcarbamylase (OTC), as a Marker for Diagnosing Brain Damages
    Publication number: 20090178152
    Abstract: The present invention pertains to the domain of brain diseases, and provides novel markers and methods for diagnosing a brain alteration in an individual, especially in patients suffering from neurodegenerative diseases such as Alzheimer's disease. The present invention also provides tools for evaluating the probability, for an individual, of developing the disease, as well as a target for identifying new drugs for treating neurodegenerative diseases such as Alzheimer's disease. In particular, the invention provides a genetic marker based on combination of two single nucleotide polymorphism, at positions ?389 and ?241 of the ornithine transcarbamylase (OTC) gene.
    Type: Application
    Filed: April 18, 2007
    Publication date: July 9, 2009
    Applicant: Genoscreen
    Inventors: Philippe Amouyel, Jean-Charles Lambert, Stéphanie Ferreira
  • Display screen or portion thereof with graphical user interface
    Patent number: D890770
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: July 21, 2020
    Assignee: GENOSCREEN
    Inventor: Cyril Gaudin